Sarah Cannon reaches more than 100,000 patients diagnosed with cancer annually through our network across the United States and United Kingdom, which allows our team to have the broadest perspective on cancer care delivery.
Sarah Cannon's recognized physician leadership is at the forefront of shaping new standards of cancer care based upon the latest research.
Sarah Cannon provides patients with access to novel therapies through one of the largest early-phase clinical trial programs in the world.
Patient-centric, Sarah Cannon offers individualized plans to support and navigate those living with cancer through the entire care journey from discovery through recovery.
Sarah Cannon's physician-led oversight drives quality standards and program development to build centers of excellence for every major cancer type.
Sarah Cannon’s integrated delivery of cancer programs enables tracking and measuring of patient data to obtain better care outcomes.